Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,036 | -5,135 | -3,248 | -1,195 | -10,594 |
| Depreciation Amortization | 12 | 9 | 6 | 3 | 37 |
| Income taxes - deferred | 824 | -187 | -111 | -51 | -223 |
| Accounts receivable | -121 | -172 | -137 | -239 | 4 |
| Accounts payable and accrued liabilities | -23 | -7 | -18 | -13 | -1 |
| Other Working Capital | -1,614 | -624 | -182 | -319 | -86 |
| Other Operating Activity | 5,360 | 1,042 | 834 | 400 | 6,300 |
| Operating Cash Flow | $-7,598 | $-5,073 | $-2,857 | $-1,413 | $-4,564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -18 | N/A | N/A | N/A |
| Purchase Of Investment | -789 | -1,215 | -422 | -282 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 148 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -373 |
| Investing Cash Flow | $-806 | $-1,233 | $-422 | $-282 | $-225 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4 | N/A | N/A | 5 | -381 |
| Debt Issued | 237 | 237 | 237 | -239 | 2,684 |
| Debt Repayment | -307 | -311 | -311 | 237 | N/A |
| Common Stock Issued | 11,120 | 6,875 | 0 | 40 | 7,615 |
| Other Financing Activity | -1,058 | -1,058 | 0 | 0 | -350 |
| Financing Cash Flow | $9,996 | $5,743 | $-75 | $42 | $9,568 |
| Exchange Rate Effect | -28 | 12 | 9 | -15 | 62 |
| Beginning Cash Position | 5,001 | 5,001 | 5,001 | 5,001 | 160 |
| End Cash Position | 6,565 | 4,450 | 1,657 | 3,333 | 5,001 |
| Net Cash Flow | $1,564 | $-552 | $-3,344 | $-1,668 | $4,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,598 | -5,073 | -2,857 | -1,413 | -4,564 |
| Capital Expenditure | -18 | -18 | 0 | N/A | N/A |
| Free Cash Flow | -7,615 | -5,091 | -2,857 | -1,413 | -4,564 |